| Literature DB >> 28358911 |
Massimo Cesareo1, Elena Ciuffoletti1, Alessio Martucci1, Jacopo Sebastiani1, Roberto Pietro Sorge2, Eleonora Lamantea3, Barbara Garavaglia3, Federico Ricci1, Andrea Cusumano1, Carlo Nucci1, Francesco Brancati4,5.
Abstract
BACKGROUND: To assess posterior pole (PP) retinal structure in patients with genetically confirmed autosomal dominant optic atrophy (ADOA) using new spectral domain optical coherence tomography (SD-OCT) segmentation technology. To analyze retinal PP thickness in relation to retinal sensitivity data from microperimetry (MP) in ADOA patients. METHODS ANDEntities:
Mesh:
Year: 2017 PMID: 28358911 PMCID: PMC5373574 DOI: 10.1371/journal.pone.0174560
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Posterior Pole numeric map of retinal differential light sensitivity of MP1 of a healthy subject.
Fig 2Combination map of SD-OCT PP total retina and MP1 PP map.
OPA1 mutations, clinical and demographic data in 9 patients with ADOA.
| Family | Patient number | Sex | Age (y) | OPA1 gene site | Nucleotide Change | Amino Acid Change | Visual acuity (R/L) |
|---|---|---|---|---|---|---|---|
| A | 1 | F | 11 | Intron 14 | c.1377+3A>T | Splicing defect | 0,2/0,1 |
| A | 2 | M | 48 | Intron 14 | c.1377+3A>T | Splicing defect | 0,0/0,1 |
| B | 3 | M | 26 | Exon 25 | c.2481_2501del | p.Lys828_Lys834del | 0,4/0,4 |
| C | 4 | M | 51 | Exon 29 | c.2873_2876del | p.Val958Glyfs*3 | 0,7/0,7 |
| C | 5 | F | 43 | Exon 29 | c.2873_2876del | p.Val958Glyfs*3 | 0,1/0,1 |
| C | 6 | F | 22 | Exon 29 | c.2873_2876del | p.Val958Glyfs*3 | 0,5/0,5 |
| C | 7 | M | 22 | Exon 29 | c.2873_2876del | p.Val 958Glyfs*3 | 1,0/0,7 |
| C | 8 | F | 66 | Exon 29 | c.2873_2876del | p.Val 958Glyfs*3 | 0,1/0,2 |
| C | 9 | F | 60 | Exon 29 | c.2873_2876del | p.Val 958Glyfs*3 | 0,4/0,4 |
| D | 10 | F | 32 | Exon 8 | c.815T>C | p.L272P | 1,2/1,2 |
| E | 11 | M | 22 | Exon 19 | c.1870delG | Splicing defect | 0,5/0,4 |
a Variants are described according to OPA1 transcript variant 8 (RefSeq: NM_130837.2)
b R/L: Right/Left Eye
Posterior Pole Retinal Layers Thickness values and Statistical Differences between Patients with ADOA and controls.
| Group | Thickness (μn) | Retina | RNFL | GCL | IPL | INL | OPL | ONL | RPE | IRL | ORL | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 262,76 | 22,77 | 21,45 | 18,92 | 30,88 | 26,40 | 60,50 | 13,70 | 183,80 | 78,50 | |||||
| 24,29 | 13,61 | 4,662 | 4,68 | 6,52 | 3,80 | 12,20 | 3,20 | 51,27 | 3,81 | |||||
| 299,46 | 42,24 | 33,61 | 27,86 | 32,01 | 25,70 | 58,10 | 13,90 | 219,97 | 79,35 | |||||
| 34,53 | 28,15 | 10,41 | 9,82 | 5,27 | 3,20 | 10,40 | 2,02 | 33,09 | 5,12 | |||||
| .0001 | .0001 | .0001 | .0001 | .0001 | .001 | .001 | .06 | .0001 | .34 | |||||
Retina: total retinal thickness; RNFL: Retinal Nerve Fiber Layer; GCL: Ganglion Cell Layer; IPL: Inner Plexiform Layer; INL: Inner Nuclear Layers; OPL: Outer Plexiform Layer; ONL: Outer Nuclear Layer; RPE: Retinal Pigment Epithelium; IRL: Inner Retinal Layers; ORL: Outer Retinal Layers
bSD: Standard Deviation
c Significant difference (p<0.05) in Anova test between normal and ADOA groups for each population.
Fig 3SD-OCT PP map of total retina, RNFL and GCL thickness of a healthy subject vs ADOA patient.
Fig 4Hyperreflective dots in 4 of 11 ADOA patients at the level of the parafoveal ONL.
Peripapillary RNFL thickness values provided by RNFL-N Axonal Analytics and Statistical Differences in Autosomal-Dominant Optic Atrophy (ADOA) and Control Subjects.
| Group | Thickness (μm) | PMB | TI | T | TS | NI | N | NS | G | N/T |
|---|---|---|---|---|---|---|---|---|---|---|
| 20,22 | 92,38 | 27 | 67,67 | 73 | 55,28 | 82,5 | 60,06 | 2,20 | ||
| 6,025 | 19,01 | 5,77 | 18,62 | 12,99 | 10,72 | 18,83 | 8,46 | 0,62 | ||
| 51,8 | 143,2 | 66,8 | 137,3 | 117,1 | 76,6 | 107,6 | 99 | 1,16 | ||
| 5,5 | 13,0 | 5,4 | 19,5 | 24,3 | 17,9 | 28,3 | 12,4 | 0,3 | ||
| .001 | .001 | .001 | .001 | .001 | .001 | .001 | .001 | .001 | ||
aPMB: papillo-macular bundle; TI: temporal-inferior; T: temporal; TS:temporal-superior; NI: nasal-inferior; N: nasal; NS: nasal-superior; G: global; N/T: nasal-to-temporal ratio
bSD: Standard Deviation
: Significant difference (P<0.05) in Anova test between normal and ADOA groups for each population.
Mean ± standard deviation retinal sensitivity values of the 64 test-points measured by the MP1 “posterior pole” program in Autosomal-Dominant Optic Atrophy (ADOA) and Control Subjects.
| 11,45 ± 3,44 | 12,23 ± 3,07 | 14,18 ± 3,11 | 15,23 ± 2,32 | 14,18 ± 2,95 | 14,41 ± 1,65 | 13,77 ± 2,63 | 12,64 ± 4,46 | ||
| 12,64 ± 4,16 | 14,05 ± 3,69 | 14,82 ± 3,67 | 16,23 ± 3,61 | 15,32 ± 4,45 | 15,50 ± 3,73 | 14,86 ± 3,28 | 14,68 ± 3,10 | ||
| 13,18 ± 4,15 | 14,68 ± 4,47 | 15,50 ± 5, 44 | 15,41 ± 6,13 | 16,82 ± 2,42 | 17,41 ± 3,94 | 15,64 ± 4,35 | 15,05 ± 4,20 | ||
| 12,27 ± 4,69 | 14,32 ± 5,82 | 15,41 ± 4,95 | 14,86 ± 5,31 | 15,41 ± 5,22 | 17,41 ± 4,81 | 16,64 ± 3,30 | 16,41 ± 2,26 | ||
| 6,22 ± 6,69 | 11,32 ± 6,29 | 12,28 ±6,78 | 11,23 ± 8,92 | 16,64 ± 4,81 | 16,91 ± 4,23 | 17,36 ± 3,09 | 16,0 ± 3,13 | ||
| 9,40 ± 6,63 | 9,54 ± 7,20 | 11,5 ± 7,20 | 12,50 ± 7,54 | 15,23 ± 5,84 | 16,45 ± 5,16 | 15,68 ± 3,16 | 14,77 ± 3,81 | ||
| 9,09 ± 6,42 | 10,82 ± 7,06 | 12,82 ± 6,65 | 12,00 ± 6,90 | 14,73 ± 5,47 | 14,73 ± 4,78 | 15,50 ± 4,24 | 14,23 ± 3,66 | ||
| 8,54 ± 6,82 | 10,23 ± 6,41 | 10,00 ± 5,36 | 11,68 ± 6,38 | 12,86 ± 5,72 | 13,64 ± 4,08 | 12,68 ± 5,05 | 12,45 ± 3,66 | ||
| 16,28 ± 2,95 | 16,06 ± 2,34 | 16,83 ± 2,12 | 16,61 ± 1,91 | 17,78 ± 2,16 | 17,22 ± 2,18 | 16,44 ± 2,62 | 16,67 ± 2,47 | ||
| 16,61 ± 2,25 | 17,61 ± 2,15 | 18,17 ± 1,54 | 18,44 ± 1,62 | 18,44 ± 1,62 | 18,22 ± 1,80 | 17,33 ± 1,68 | 18,00 ± 2,28 | ||
| 17,56 ± 2,12 | 18,83 ± 1,54 | 19,67 ± 0,77 | 19,56 ± 0,86 | 19,67 ± 0,77 | 19,67 ± 0,77 | 19,33 ± 1,68 | 18,67 ± 1,68 | ||
| 18,50 ± 1,38 | 19,56 ± 0,86 | 19,89 ± 0,47 | 19,67 ± 1,03 | 19,89 ± 0,47 | 19,89 ± 0,47 | 19,67 ± 0,77 | 19,67 ± 0,77 | ||
| 18,89 ± 1,57 | 19,89 ± 0,47 | 19,89 ± 0,47 | 19,89 ± 0,47 | 20,00 ± 0,00 | 20,00 ± 0,00 | 19,56 ± 0,86 | 19,56 ± 1,29 | ||
| 18,78 ± 1,40 | 19,44 ± 0,92 | 19,78 ± 0,65 | 20,00 ± 0,00 | 19,78 ± 0,65 | 19,78 ± 0,65 | 19,78 ±0,65 | 19,22 ± 1,70 | ||
| 17,67 ± 2,40 | 19,00 ± 1,24 | 19,61 ± 0,92 | 20,00 ± 0,00 | 20,00 ± 0,00 | 19,89 ± 0,47 | 19,78 ± 0,65 | 19.78 ± 0,94 | ||
| 17,39 ± 1,58 | 18,50 ± 1,62 | 19,00 ± 1,41 | 19,67 ± 1,03 | 19,56 ± 1,10 | 18,44 ± 4,20 | 19,33 ± 1,19 | 19,56 ± 0,86 | ||
a S: superior; N: nasal; T: temporal; I: inferior
Mean PP differential sensitivity values measured by MP1 comparing Autosomal-Dominant Optic Atrophy (ADOA) and Control Subjects.
| Group | Retinal Sensitivity (dB) | Total |
|---|---|---|
| 12,86 | ||
| 6,18 | ||
| 18,76 | ||
| 1,87 | ||
| .001 |
aSD: Standard Deviation
b: Significant difference (P<0.05) in Anova test between normal and ADOA groups for each population
Fig 5Combination map of SD-OCT GCL and MP1 PP map of a healthy subject vs ADOA patient.